{"filing":{"accession_number":"0001213900-26-063575","cik":"0001558569","ticker":"ISPC","company_name":"iSpecimen Inc.","form":"8-K","filing_date":"2026-06-01","report_date":null,"primary_document":"ea0292875-8k_ispecimen.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1558569/000121390026063575/ea0292875-8k_ispecimen.htm"},"events":[{"id":7867,"run_id":6903,"accession_number":"0001213900-26-063575","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"iSpecimen received a formal notice from Nasdaq on May 29, 2026, that it fails to comply with Listing Rule 5550(b)(1), which requires minimum stockholders' equity of $2,500,000. The Company reported only $814,038 in stockholders' equity as of March 31, 2026, and does not meet any of the alternative continued listing standards. While the Company has 45 days to submit a compliance plan and potential 180-day extension, the notice represents a material delisting risk that would significantly affect investor assessment of the registrant's continued public trading status.","company_name":"iSpecimen Inc.","ticker":"ISPC","filing_date":"2026-06-01","submitted_at":null,"items":[{"id":3243,"accession_number":"0001213900-26-063575","item_number":"3.01","item_title":"Notice of Delisting or Failure to","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"iSpecimen received a formal notice from Nasdaq on May 29, 2026, that it fails to comply with Listing Rule 5550(b)(1), which requires minimum stockholders' equity of $2,500,000. The Company reported only $814,038 in stockholders' equity as of March 31, 2026, and does not meet any of the alternative continued listing standards. While the Company has 45 days to submit a compliance plan and potential 180-day extension, the notice represents a material delisting risk that would significantly affect investor assessment of the registrant's continued public trading status.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-02T02:45:54.518910+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3243,"accession_number":"0001213900-26-063575","item_number":"3.01","item_title":"Notice of Delisting or Failure to","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"iSpecimen received a formal notice from Nasdaq on May 29, 2026, that it fails to comply with Listing Rule 5550(b)(1), which requires minimum stockholders' equity of $2,500,000. The Company reported only $814,038 in stockholders' equity as of March 31, 2026, and does not meet any of the alternative continued listing standards. While the Company has 45 days to submit a compliance plan and potential 180-day extension, the notice represents a material delisting risk that would significantly affect investor assessment of the registrant's continued public trading status.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-02T02:45:54.518910+00:00","company_name":"iSpecimen Inc.","ticker":"ISPC","filing_date":"2026-06-01"}]}